K-pop

Lee Hi and Dok2’s World Tour Canceled… “Organizer Has Not Completed Payment”

"Received a cancellation notice from the organizer" "We will proceed with the necessary legal procedures"

KIM HYUNSIK
2026-08-05 14:14:27
[Edaily Starin KIM HYUNSIK Reporter] Singers Lee Hi and Dok2 announced the cancellation of their world tour.
Lee Hi (left), Dok2 (Photo: Dok2’s social media)
Their agency, 8O8 High Recordings, posted an announcement on its official social media accounts on the 4th, stating, “On the 2nd, we were notified by the tour organizer, KINO WHITE TOURING KOREA, that all performances in every city on the world tour had been canceled and that the process for refunding ticket holders had begun.”
The agency continued, “This cancellation is not due to a decision by the artists or any fault on their part,” adding, “We repeatedly extended the payment deadlines and requested fulfillment of contractual obligations to ensure the concerts could proceed, but the organizer notified us of the tour’s cancellation without completing payment or making the necessary preparations.”
Ihwa and Dokki were scheduled to kick off their world tour with a performance in Singapore on the 8th, followed by shows in Manila, Hong Kong, Bangkok, Sydney, Brisbane, Melbourne, and Auckland through next month.
808 High Recordings stated, “Please contact the point of purchase where you bought your tickets for details regarding ticket refunds,” adding, “We sincerely apologize to everyone who has been looking forward to the tour, and we plan to pursue the necessary legal proceedings regarding this matter.”
Meanwhile, Lee Hi and Dok2 announced in March that they had co-founded the music label 808 High Recordings. Subsequently, they revealed they were in a romantic relationship, sparking widespread attention.

Economy

Corporation

IT·Science

Economy

[Market In] E-Land World Moves to Issue 40 Billion Won in Corporate Bonds, Defying the BBB-Rating Downturn

E-Land World (BBB0) is set to issue up to 40 billion won in public corporate bonds. With investor sentiment toward BBB-rated corporate bonds currently subdued, all eyes are on whether the company can …
2026-08-07 18:54:04

Corporation

MedPacto, Inc. Adds Medium-Dose Group to Phase 2 Trial of Baekto-Seetip for Osteosarcoma… Files Application to Amend IND

(Photo courtesy of MedPacto, Inc.) MedPacto, Inc.(235980)is adding a medium-dose patient group to the Phase 2 clinical trial of “Vactosertib,” which it is developing as a treatment for osteosarcom…
2026-08-07 18:21:02

IT·Science

Coreline Soft Co., Ltd. Signs Contract for Lung Cancer Screening Project in Germany… A 10-Year “Jackpot”

Medical artificial intelligence (AI) company Coreline Soft Co., Ltd.(384470)announced on the 7th that it has secured a contract for a lung cancer screening project in Lostau, Germany, through Canon Me…
2026-08-07 18:44:02